Accelerating Clinical Development With Cloud Integration

The Veeva 2020 Unified Clinical Operations Survey Report uncovered that life sciences companies rank integrating multiple applications as their top challenge with clinical technology.

As a result, life sciences companies are adopting API-led strategies so their investments in accessing and extending their core assets and processes can return greater value. With an API-led strategy, these systems can now utilize increased automation, making it far easier to coordinate with adjacent programs. Using this approach, the investments around accessing clinical trial management systems, R&D systems, and trial observation systems are reusable for other integration patterns. The same definition of a concept, like an adverse event, is relevant both during a trial and once approved. By using an API-led strategy, these definitions can be built once, reused many times, and become the composable foundation for many other types of integrations.